Adagio Medical Holdings Cash Flow from Operating Activities 2020-2024 | ADGM
Adagio Medical Holdings cash flow from operating activities from 2020 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
| Adagio Medical Holdings Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2024 | $-29 |
| 2023 | $-26 |
| 2022 | $0 |
| 2021 | $-1 |
| 2020 | $0 |
| 2019 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.019B | $0.001B |
| Adagio Medical is a developmental stage medical device company which focuses on developing cryoablation technologies which create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter and ventricular tachycardia. Adagio Medical, formerly known as ARYA Sciences Acquisition Corp IV, is based in LAGUNA HILLS, Calif. | |||